Recruitment

Recruitment Status
Recruiting
Estimated Enrollment
Same as current

Summary

Conditions
Prostatic Neoplasms
Type
Interventional
Phase
Not Applicable
Design
Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment

Participation Requirements

Age
Between 18 years and 75 years
Gender
Only males

Description

Not Provided

Not Provided

Tracking Information

NCT #
NCT02102477
Collaborators
Not Provided
Investigators
Principal Investigator: Johan Stranne, M.D ass prof Sahlgrenska University Hospital, Department of Urology, SE- 413 45 Gothenburg Principal Investigator: Camilla Thellenberg Karlsson, MD, PhD Umeå University Hospital, Department of Radiation Science, SE-901 87 Umeå Sweden Principal Investigator: Eva M Johansson, R.N PhD Karolinska Institute, Nobelsväg, SE- 171 77 Solna, Sweden Principal Investigator: Gunnar Steineck, M.D Prof Karolinska Institute, Nobelsväg, SE-171 77 Solna, Sweden Principal Investigator: Klaus Brasso, M.D Rigshospitalet, department Urology, DK-2001-Copenhagen, Denmark Principal Investigator: Peter M Meidahl Petersen, M.D ass prof Rigshospitalet, Region h, Department of Oncology, Blegdamsvej 9, DK- 2001, Copenhagen, Denmark Principal Investigator: Bjørn Brennhovd, M.D ass.prof Oslo University Hospital, Department of Urology, P.O Box 4950 Nydalen, N-0424, Oslo Norway Principal Investigator: Wolfgang Lilleby, M.D ass.prof Oslo University Hospital, Department of Radiation Therapy, P.O Box 4950, N-0424, Nydalen Oslo, Norway Principal Investigator: Antti Rannikko, M.D ass.prof Helsinki University Central Hospital, Department Urology,Stenbäckinkatu 9, FIN-00290 Helsinki , Finland Principal Investigator: Mauri Kouri, M.D PhD Helsinki University Central Hospital, Department Urology,Stenbäckinkatu 9, FIN-00290 Helsinki , Finland Principal Investigator: Tuomas Mirtti, M.D PhD Helsinki University Central Hospital, Department Urology,Stenbäckinkatu 9, FIN-00290 Helsinki , Finland